Terri Sebree

President, Zynerba Pharmaceuticals

Contact Information

Professional Background

Terri B. Sebree has served as our President since October 2014. Ms. Sebree has more than 35 years of executive, development, and operational experience in the biopharmaceutical industry, particularly in CNS product development including epilepsy, pain, depression, and schizophrenia. She has completed more than 10 regulatory submissions and approvals of new pharmaceutical products, including transdermal patch and gel products.

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

This program is open to all eligible individuals. SC CTSI operates all of its programs and activities consistent with the University’s Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor.